A clinical trial of multiple peptides vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS.
A clinical trial of multiple peptides vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS. Oncoimmunology. 2015 Aug; 4(8):e1022307.